Dr. Harrison Eye Care > Implantable Contacts

Introducing Visian ICL™ With Collamer^® Technology

Introducing Visian ICL™, a new phakic intraocular lens that is revolutionizing refractive surgery. Visian ICL™ is made of Collamer^®, an advanced lens material that provides exceptional quality of vision and biocompatibility. Consider the many advantages of Visian ICL™ that are now unfolding.

In an evaluation of optical quality of the ICL compared to LASIK, the ICL induced significantly less higher order aberrations¹
Visian ICL™ provides exceptional quality of vision
More than 99% of patients report satisfaction 3 years postprocedure²

Placement of Visian ICL™ is safe and discreet and provides an ideal platform for future toric correction
State-of-the-art implantation procedure allows for small incision and offers predicatable outcomes in an outpatient setting

Collamer^® has been shown to exhibit less internal reflectance than other lens materials including silicone, acrylic, and PMMA³
Collamer^® contains negatively charged collagen that inhibits protein binding⁴
Collamer^® biocompatibility reduces the risk of long-term inflammation⁵

The Visian ICL™ offers a wide range of vision correction including myopia, hyperopia, and astigmatism (market approval varies by country)
Visian ICL™ complements your practice and your patients' needs

For more information, click here.

References
1. Sarver EJ, Sanders DR, Vukich JA. Image quality in myopic eyes corrected with laser in situ keratomileusis and phakic intraocular lens. J refract Surg. 2003;19(4):397-404.	2. UV-absorbing collamer implantable contact lens (ICL) for the correction of myopia. PMA# P030016. Presentation to the Ophthalmic Devices Advisory Panel. October 3, 2003.	3. Ossipov A. Comparison of internal reflectance patterns of Collamer, acrylic and silicone. 1997. Data on file, STAAR Surgical.	4. Toselli P, Mogayzel PJ Jr, Faris B, Ferrera R, Franzblau C. Mammalian cell growth on collagen-hydrogels. Scan Electron Microsc. 1984;(Pt 3):1301-1312.	5. Davis EA. Study of post-cataract surgery inflammation with 3 different IOLs (Collamer, SI40NB, AR40). Summary of data found in all patients. Presented at OSN Meeting: October 2003; New York, NY.